ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,69%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
83,95
0,47%
Bitcoin
63 148,34
3,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Artelo Biosciences Inc (ARTL)

  7. Artelo Biosciences Inc (ARTL) Actualités

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateHeureSourceTitreSymboleSociété
23/04/202414h30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
22/04/202414h30GlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
25/03/202413h00GlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
12/03/202414h15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
23/01/202414h30GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
08/01/202414h30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
05/12/202314h30GlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
30/11/202315h00GlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
13/11/202314h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
13/11/202314h00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
09/11/202315h00GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
02/11/202313h30GlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
04/10/202314h30GlobeNewswire Inc.Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaNASDAQ:ARTLArtelo Biosciences Inc
13/09/202314h30GlobeNewswire Inc.Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thNASDAQ:ARTLArtelo Biosciences Inc
07/09/202314h00GlobeNewswire Inc.Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/09/202315h00GlobeNewswire Inc.Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thNASDAQ:ARTLArtelo Biosciences Inc
05/09/202315h00GlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thNASDAQ:ARTLArtelo Biosciences Inc
10/08/202314h00GlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
08/08/202322h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
08/08/202322h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
19/07/202315h00GlobeNewswire Inc.Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023NASDAQ:ARTLArtelo Biosciences Inc
17/07/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARTLArtelo Biosciences Inc
10/07/202314h30GlobeNewswire Inc.Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11NASDAQ:ARTLArtelo Biosciences Inc
07/07/202314h23Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:ARTLArtelo Biosciences Inc
06/07/202322h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ARTLArtelo Biosciences Inc
28/06/202314h30GlobeNewswire Inc.Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
27/06/202314h30GlobeNewswire Inc.Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
26/06/202314h30GlobeNewswire Inc.Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
07/06/202314h30GlobeNewswire Inc.Artelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
16/05/202322h55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL

Dernières Valeurs Consultées

EU
GLE
Societe Generale
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
EU
DG
Vinci
COIN
BTCUSD
Bitcoin
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
EU
RNO
Renault
NASDAQ
MSFT
Microsoft
EU
RI
Pernod Ricard
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés